Par Pharmaceutical Companies' Acquisition

Par Pharmaceutical Companies was acquired by Endo International on May 18, 2015.

Par Pharmaceutical Companies is a privately held, U.S.-based specialty pharmaceutical company. The company develops, manufactures and markets high-barrier-to-entry generic drugs and niche, innovative …

Articles about Par Pharmaceutical Companies' Acquisition: